Please login to the form below

Not currently logged in

Dragonfly Therapeutics

This page shows the latest Dragonfly Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Gilead signs $300m deal with Dragonfly to advance immunotherapies

Gilead signs $300m deal with Dragonfly to advance immunotherapies

The partnership will make use of Dragonfly’s oncology and inflammatory disease research capabilities. ... Gilead Sciences and Dragonfly Therapeutics have announced a new partnership focused on advancing Dragonfly’s novel natural killer (NK) cell

Latest news

More from news
Approximately 3 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts


Add my company
dna Communications

Because health means everything...

Latest intelligence

Time to talk about health inequalities
Health inequalities are increasingly being recognised as a crucial healthcare challenge in the UK...
The speed of science and the pace of comms
Pharma red tape slows comms but there is a solution, Paul Hutchings, founder of fox&cat, writes....
Improving cardiovascular disease care and awareness
Scott Curley talks to PME about the risks of CVD and the importance of getting the right treatment at the right time...